Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve
Oliver K. Jawitz*, Tracy Y. Wang, Renato D. Lopes, Alma Chavez, Brittanny Boyer, Hwasoon Kim, Kevin J. Anstrom, Richard C. Becker, Eugene Blackstone, Marc Ruel, Vinod H. Thourani, John D. Puskas, Marc W. Gerdisch, Douglas Johnston, Scott Capps, John H. Alexander, Lars G. Svensson
Dive into the research topics of 'Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve'. Together they form a unique fingerprint.